NewsBenzinga모건스탠리, 모노파 테라퓨틱스 비중확대 의견 유지···목표주가 133달러로 상향 모건스탠리, 모노파 테라퓨틱스 비중확대 의견 유지···목표주가 133달러로 상향 Benzinga 2026.11.16 15:23 (GMT+0) Open on Benzinga Other news Solana Foundation Issues Urgent Security Alert: Linux Kernel Vulnerability Should Be Patched as Soon as Possible DTCC, Barclays Say Tokenization's Real Prize Is Unlocking Idle Collateral Novo Nordisk vs. Amgen: 1 Has the Blockbuster Weight-Loss Drugs, the Other Has a Promising Rival Cathie Wood and Jim Cramer Disagree on Nvidia Stock Without Jensen Huang. Earnings Could Decide Who's Right A $1.3 Billion Reason to Buy Firefly Aerospace Stock Here Audible turns to AI to help users discover audiobooks
Solana Foundation Issues Urgent Security Alert: Linux Kernel Vulnerability Should Be Patched as Soon as Possible
Cathie Wood and Jim Cramer Disagree on Nvidia Stock Without Jensen Huang. Earnings Could Decide Who's Right